Journal logo

Journal of Advanced Studies in Science

Beyond Equations, Into Humanity

By Khan584 Published 4 months ago 4 min read
Journal of Advanced Studies in Science
Photo by David Trinks on Unsplash




Chapter One – The Scientist’s Dream

Dr. Meher Ali adjusted her glasses as she stared at the flickering monitor in her laboratory. The room was quiet except for the faint hum of machines and the soft scratching of her pen against a notebook. Piles of research papers surrounded her like fortresses, each page filled with equations, genetic sequences, and scribbled notes that only she could make sense of.

Her eyes, sharp yet weary, lingered on the glowing title bar of a webpage: Journal of Advanced Studies in Science. For decades, this journal had been the crown jewel of scientific publishing. It was where the greatest discoveries in physics, biology, and technology were first revealed to the world. Publishing there was more than recognition—it was immortality.

Meher whispered softly, “One day, my work will be here. Not for fame, but so no one can erase it.”

She had reasons to be cautious. Born in a small town where resources were scarce, she had fought her way into the scientific community. She had been underestimated, doubted, and sometimes outright dismissed for being a woman in a field still dominated by older men who guarded their authority fiercely. Yet Meher persisted.

Her current project was her boldest yet: a formula that could rewrite flawed genetic codes. In theory, it could cure diseases thought incurable—Huntington’s, ALS, even certain cancers. Her prototype worked on cell cultures, showing remarkable results.

But the scientific board at her institute laughed at her proposal. “It’s dangerous, Ali,” said Professor Iqbal, the head of genetics. “Gene editing at that scale? It’s fantasy. Even if it worked, we’d never approve human trials. Submit something realistic to the Journal. Then maybe we’ll listen.”

Realistic. That word stung. To Meher, realism was watching patients die in hospitals, children suffer in silence, and families break apart because science wasn’t brave enough to try.

She wrote in her notebook: “If science stops where fear begins, then what is its purpose?”


---

Chapter Two – Shadows of Doubt

Weeks turned into months. Meher refined her formula in secrecy, perfecting algorithms that could repair DNA strands without triggering immune rejection. The more she tested, the more convinced she became: it worked.

But whispers spread. A rival scientist, Dr. Sameer Khan, began undermining her work during faculty meetings. “Dr. Ali’s theories are mathematically elegant,” he sneered once, “but science is not poetry. We need facts, not fairy tales.”

Meher bit her tongue. She had facts—stacks of them—but none recognized by the Journal yet. Without that stamp of approval, her discoveries were considered speculation.

One night, she returned to her lab to find her computer files corrupted. Hours of simulations were gone. She suspected Sameer but had no proof. Furious, she clutched her handwritten notebook to her chest. “At least you’re still here,” she whispered. That notebook, like a silent confidant, became her lifeline.

Sara, her closest friend from medical school, often visited her in the lab. “Meher,” she said one evening, “you’ve got to take care of yourself. You hardly eat. You hardly sleep. Why let this Journal consume you?”

Meher’s eyes softened. “Because if my work doesn’t appear there, it will die in obscurity. And then—what’s the point of all these years?”

Sara reached across the desk and squeezed her hand. “The point is saving lives, not winning prestige.”

But Meher only sighed, staring again at the Journal’s logo glowing on her screen.


---

Chapter Three – The Outbreak

Everything changed one bitter winter. A mysterious illness swept across the city. Patients came in with high fevers, neurological spasms, and rapid organ failure. Hospitals overflowed within days. The government declared an emergency, but no treatment worked.

At first, Meher thought it was another viral epidemic. But when she studied the sequences of the pathogen, her heart froze. It wasn’t a virus at all—it was a genetic breakdown triggered by environmental toxins, spreading silently through families with certain DNA vulnerabilities.

Her formula, the very one the board had mocked, could stabilize those genetic flaws. It wasn’t just relevant—it was humanity’s only chance.

She rushed to present her findings at an emergency scientific council. Her voice trembled but her conviction was firm. “We can use the gene-repair algorithm. I’ve tested it on cultures—it works. We can save them.”

The room buzzed with skepticism. Dr. Sameer smirked. “So now you want to play savior? This is reckless. There’s no peer-reviewed evidence. No Journal has accepted your work. We can’t gamble lives on unproven fantasies.”

“But lives are already being lost!” Meher snapped. “Every hour we wait, more children die. Are we scientists or cowards?”

Silence followed. Finally, Professor Iqbal shook his head. “Without official publication or approval, we cannot authorize this. Submit it to the Journal. If they validate it, we’ll consider trials.”

The Journal. Always the Journal. But people were dying now.

That night, Meher sat in her lab, tears blurring her vision. Sara found her hunched over her notebook, scribbling furiously. “What will you do?” Sara asked gently.

Meher looked up, fire in her eyes. “If the Journal won’t listen, then I’ll bypass them. I’ll run the trials myself. Science is for humanity, not bureaucracy.”
✨ Moral:
The true purpose of science is not fame, recognition, or publication—it is to serve humanity. Knowledge without courage and compassion is meaningless; the greatest discoveries are those used to save and improve lives, even when recognition is delayed or denied.

adviceapparelhow tosatire

About the Creator

Khan584


If a story is written and no one reads it, does it ever get told

Reader insights

Be the first to share your insights about this piece.

How does it work?

Add your insights

Comments

There are no comments for this story

Be the first to respond and start the conversation.

Sign in to comment

    Find us on social media

    Miscellaneous links

    • Explore
    • Contact
    • Privacy Policy
    • Terms of Use
    • Support

    © 2026 Creatd, Inc. All Rights Reserved.